722 related articles for article (PubMed ID: 26556856)
1. Leptin as a mediator of tumor-stromal interactions promotes breast cancer stem cell activity.
Giordano C; Chemi F; Panza S; Barone I; Bonofiglio D; Lanzino M; Cordella A; Campana A; Hashim A; Rizza P; Leggio A; Győrffy B; Simões BM; Clarke RB; Weisz A; Catalano S; Andò S
Oncotarget; 2016 Jan; 7(2):1262-75. PubMed ID: 26556856
[TBL] [Abstract][Full Text] [Related]
2. Activated FXR Inhibits Leptin Signaling and Counteracts Tumor-promoting Activities of Cancer-Associated Fibroblasts in Breast Malignancy.
Giordano C; Barone I; Vircillo V; Panza S; Malivindi R; Gelsomino L; Pellegrino M; Rago V; Mauro L; Lanzino M; Panno ML; Bonofiglio D; Catalano S; Andò S
Sci Rep; 2016 Feb; 6():21782. PubMed ID: 26899873
[TBL] [Abstract][Full Text] [Related]
3. Effect of fibroblasts on breast cancer cell mammosphere formation and regulation of stem cell-related gene expression.
Zhang F; Song C; Ma Y; Tang L; Xu Y; Wang H
Int J Mol Med; 2011 Sep; 28(3):365-71. PubMed ID: 21573501
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D compounds reduce mammosphere formation and decrease expression of putative stem cell markers in breast cancer.
Wahler J; So JY; Cheng LC; Maehr H; Uskokovic M; Suh N
J Steroid Biochem Mol Biol; 2015 Apr; 148():148-55. PubMed ID: 25445919
[TBL] [Abstract][Full Text] [Related]
5. The Hedgehog signalling pathway mediates drug response of MCF-7 mammosphere cells in breast cancer patients.
He M; Fu Y; Yan Y; Xiao Q; Wu H; Yao W; Zhao H; Zhao L; Jiang Q; Yu Z; Jin F; Mi X; Wang E; Cui Z; Fu L; Chen J; Wei M
Clin Sci (Lond); 2015 Nov; 129(9):809-22. PubMed ID: 26201092
[TBL] [Abstract][Full Text] [Related]
6. Interaction with adipocyte stromal cells induces breast cancer malignancy via S100A7 upregulation in breast cancer microenvironment.
Sakurai M; Miki Y; Takagi K; Suzuki T; Ishida T; Ohuchi N; Sasano H
Breast Cancer Res; 2017 Jun; 19(1):70. PubMed ID: 28629450
[TBL] [Abstract][Full Text] [Related]
7. MiR-221 promotes stemness of breast cancer cells by targeting DNMT3b.
Roscigno G; Quintavalle C; Donnarumma E; Puoti I; Diaz-Lagares A; Iaboni M; Fiore D; Russo V; Todaro M; Romano G; Thomas R; Cortino G; Gaggianesi M; Esteller M; Croce CM; Condorelli G
Oncotarget; 2016 Jan; 7(1):580-92. PubMed ID: 26556862
[TBL] [Abstract][Full Text] [Related]
8. Involvement of adiponectin and leptin in breast cancer: clinical and in vitro studies.
Jardé T; Caldefie-Chézet F; Goncalves-Mendes N; Mishellany F; Buechler C; Penault-Llorca F; Vasson MP
Endocr Relat Cancer; 2009 Dec; 16(4):1197-210. PubMed ID: 19661131
[TBL] [Abstract][Full Text] [Related]
9. Targeting highly expressed extracellular HSP90 in breast cancer stem cells inhibits tumor growth in vitro and in vivo.
Stivarou T; Stellas D; Vartzi G; Thomaidou D; Patsavoudi E
Cancer Biol Ther; 2016 Aug; 17(8):799-812. PubMed ID: 27259689
[TBL] [Abstract][Full Text] [Related]
10. Regulation of the inflammatory profile of stromal cells in human breast cancer: prominent roles for TNF-α and the NF-κB pathway.
Katanov C; Lerrer S; Liubomirski Y; Leider-Trejo L; Meshel T; Bar J; Feniger-Barish R; Kamer I; Soria-Artzi G; Kahani H; Banerjee D; Ben-Baruch A
Stem Cell Res Ther; 2015 May; 6(1):87. PubMed ID: 25928089
[TBL] [Abstract][Full Text] [Related]
11. Breast cancer stromal fibroblasts promote the generation of CD44+CD24- cells through SDF-1/CXCR4 interaction.
Huang M; Li Y; Zhang H; Nan F
J Exp Clin Cancer Res; 2010 Jun; 29(1):80. PubMed ID: 20569497
[TBL] [Abstract][Full Text] [Related]
12. Proteomics using mammospheres as a model system to identify proteins deregulated in breast cancer stem cells.
Li G; Zhao F; Cui Y
Curr Mol Med; 2013 Mar; 13(3):459-63. PubMed ID: 23331018
[TBL] [Abstract][Full Text] [Related]
13. Propofol Reduced Mammosphere Formation of Breast Cancer Stem Cells via PD-L1/Nanog
Zhang X; Li F; Zheng Y; Wang X; Wang K; Yu Y; Zhao H
Oxid Med Cell Longev; 2019; 2019():9078209. PubMed ID: 30906504
[TBL] [Abstract][Full Text] [Related]
14. Leptin attenuates the anti-estrogen effect of tamoxifen in breast cancer.
Chen X; Zha X; Chen W; Zhu T; Qiu J; Røe OD; Li J; Wang Z; Yin Y
Biomed Pharmacother; 2013 Feb; 67(1):22-30. PubMed ID: 23199901
[TBL] [Abstract][Full Text] [Related]
15. Leptin/HER2 crosstalk in breast cancer: in vitro study and preliminary in vivo analysis.
Fiorio E; Mercanti A; Terrasi M; Micciolo R; Remo A; Auriemma A; Molino A; Parolin V; Di Stefano B; Bonetti F; Giordano A; Cetto GL; Surmacz E
BMC Cancer; 2008 Oct; 8():305. PubMed ID: 18945363
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA expression analysis of mammospheres cultured from human breast cancers.
Feifei N; Mingzhi Z; Yanyun Z; Huanle Z; Fang R; Mingzhu H; Mingzhi C; Yafei S; Fengchun Z
J Cancer Res Clin Oncol; 2012 Nov; 138(11):1937-44. PubMed ID: 22752669
[TBL] [Abstract][Full Text] [Related]
17. Hormonal Therapy Resistance and Breast Cancer: Involvement of Adipocytes and Leptin.
Delort L; Bougaret L; Cholet J; Vermerie M; Billard H; Decombat C; Bourgne C; Berger M; Dumontet C; Caldefie-Chezet F
Nutrients; 2019 Nov; 11(12):. PubMed ID: 31756890
[TBL] [Abstract][Full Text] [Related]
18. [Influence factors on the formation of mammospheres from breast cancer stem cells].
Huang MZ; Zhang FC; Zhang YY
Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Oct; 40(5):500-4. PubMed ID: 18931713
[TBL] [Abstract][Full Text] [Related]
19. Lentivirus-mediated RNA interference targeting the ObR gene in human breast cancer MCF-7 cells in a nude mouse xenograft model.
Xue RQ; Gu JC; DU ST; Yu W; Wang Y; Zhang ZT; Bai ZG; Ma XM
Chin Med J (Engl); 2012 May; 125(9):1563-70. PubMed ID: 22800822
[TBL] [Abstract][Full Text] [Related]
20. Targeting CXCR1/2 significantly reduces breast cancer stem cell activity and increases the efficacy of inhibiting HER2 via HER2-dependent and -independent mechanisms.
Singh JK; Farnie G; Bundred NJ; Simões BM; Shergill A; Landberg G; Howell SJ; Clarke RB
Clin Cancer Res; 2013 Feb; 19(3):643-56. PubMed ID: 23149820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
